TerminatedNCT00939887

A Study Of Kappa Opioid Receptor Occupancy Of PF-04455242, Using PET (Positron Emission Tomography)

Medication studyAges 18–55United StatesBipolarity

The study in practice

Understand this study

Listed age limits: 18 years to 55 years.

Listed locations: New Haven and 2 more locationsSee all locations and recruitment
Study phase: Phase 1

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateSeptember 2009

Recruitment status: Terminated
Enrollment listed in the registry: 12
Sponsor: Pfizer
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 1
Locations: United States
Age range: From 18 Years to 55 Years
Official registry ID: NCT00939887
Official title: Show the full official title
A Phase 1, Healthy Volunteer Qualification Of Ligand [11C] PF-04767135 And Randomized Determination Of Kappa Opioid Receptor Occupancy Of PF-04455242, Using PET

Terminated

New Haven

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is Pfizer.

Does this study involve medication?

Yes. The study involves medication, including PF-04455242.

Who can participate?

Listed age limits: 18 years to 55 years.

Is this study still recruiting?

The registry lists this study as terminated.

Explore other studies

Explore HopeStage studies by mental health topic and refine the results to suit your situation.